Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center

References

• American Cancer SocietyCancer Facts & Figures2016 Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2016/cancer-facts-and-figures-2016.pdfAccessed March 1, 2018
   Google Scholar
• CarrilloENavarroSARamírezA5-Fluorouracil derivatives: a patent review (2012–2014)Expert Opin Ther Pat201525101131114426165922
   PubMed Web of Science ®Google Scholar
• WeinbergBAMarshallJLHartleyMSalemMEA paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancerClin Adv Hematol Oncol201614211612827057810
   PubMedGoogle Scholar
• McquadeRMStojanovskaVBornsteinJCNurgaliKColorectal cancer chemotherapy: the evolution of treatment and new approachesCurr Med Chem201724151537155728079003
   PubMed Web of Science ®Google Scholar
• TwelvesCVision of the future: capecitabineOncologist20016Suppl 4353911585973
   PubMed Web of Science ®Google Scholar
• GórnaśMSzczylikCOral treatment of metastatic breast cancer with capecitabine: what influences the decision-making process?Eur J Cancer Care2010191131136
   Web of Science ®Google Scholar
• van CutsemEHoffPMHarperPOral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trialsBr J Cancer20049061190119715026800
   PubMed Web of Science ®Google Scholar
• HiraoCMikoshibaNShibutaTAdherence to oral chemotherapy medications among gastroenterological cancer patients visiting an outpatient clinicJpn J Clin Oncol201747978679428633481
   PubMed Web of Science ®Google Scholar
• FontREspinasJALayosLAdherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?Ann Oncol201728483183528327898
   PubMed Web of Science ®Google Scholar
• Figueiredo JuniorAGForonesNMStudy on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancerArq Gastroenterol201451318619125296077
   PubMedGoogle Scholar
• AmlaniAKumarARuanJYCheungWYCompliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record dataCancer Med2016581776178227228415
   PubMed Web of Science ®Google Scholar
• Fernández-RibeiroFOlivera-FernándezRCrespo-DizCAdherence and safety study in patients on treatment with capecitabineFarm Hosp201741220422128236798
   PubMedGoogle Scholar
• WinterhalderRHoesliPDelmoreGSelf-reported compliance with capecitabine: findings from a prospective cohort analysisOncology2011801–2293321606661
   PubMed Web of Science ®Google Scholar
• TimmersLSwartELBoonsCCThe use of capecitabine in daily practice: a study on adherence and patients’ experiencesPatient Prefer Adherence2012674174823118530
   PubMed Web of Science ®Google Scholar
• MayerELPartridgeAHHarrisLNTolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancerBreast Cancer Res Treat2009117361562319294501
   PubMed Web of Science ®Google Scholar
• PartridgeAHArcherLKornblithABAdherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104J Clin Oncol201028142418242220368559
   PubMed Web of Science ®Google Scholar
• WalterTWangLChukKNgPTannockIFKrzyzanowskaMKAssessing adherence to oral chemotherapy using different measurement methods: Lessons learned from capecitabineJ Oncol Pharm Pract201420424925624022406
   PubMed Web of Science ®Google Scholar
• ZahrinaAKNorsa’adahBHassanNBAdherence to capecitabine treatment and contributing factors among cancer patients in MalaysiaAsian Pac J Cancer Prev201415219225923225422205
   PubMedGoogle Scholar
• KawakamiKYokokawaTKobayashiKSelf-reported adherence to capecitabine on XELOX treatment as adjuvant therapy for colorectal cancerOncol Res20172591625163128766482
   PubMed Web of Science ®Google Scholar
• AllenJWilliamsonSOver compliance with capecitabine oral chemotherapyInt J Clin Pharm201436227127324532364
   PubMed Web of Science ®Google Scholar
• SpoelstraSLGivenBAGivenCWAn intervention to improve adherence and management of symptoms for patients prescribed oral chemotherapy agents: an exploratory studyCancer Nurs2013361182823235499
   PubMed Web of Science ®Google Scholar
• BourmaudAHeninETinquautFAdherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methodsBMC Res Notes2015829126142140
   PubMedGoogle Scholar
• BhattacharyaDEasthallCWilloughbyKASmallMWatsonSCapecitabine non-adherence: exploration of magnitude, nature and contributing factorsJ Oncol Pharm Pract201218333334222298660
   PubMedGoogle Scholar
• BhattacharyaDWrightDJPurvisJRCorlettAJNon-adherence in older people; intentional or unintentional?Int J Pharm Pract200412R63
   Google Scholar
• StavropoulouCNon-adherence to medication and doctor-patient relationship: Evidence from a European surveyPatient Educ Couns201183171320541884
   PubMed Web of Science ®Google Scholar
• TrevinoKMFascianoKPrigersonHGAlliance P-OncologistPatient-oncologist alliance, psychosocial well-being, and treatment adherence among young adults with advanced cancerJ Clin Oncol201331131683168923530105
   PubMed Web of Science ®Google Scholar
• RuddyKMayerEPartridgeAPatient adherence and persistence with oral anticancer treatmentCA Cancer J Clin2009591566619147869
   PubMed Web of Science ®Google Scholar
• BrettJFenlonDBoultonMFactors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancerEur J Cancer Care2018271e12601
   Web of Science ®Google Scholar
• StantonALPetrieKJPartridgeAHContributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registryBreast Cancer Res Treat2014145252553424781972
   PubMed Web of Science ®Google Scholar
• HorneRBuickDFisherMLeakeHCooperVWeinmanJDoubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAARTInt J STD AIDS2004151384414769170
   PubMed Web of Science ®Google Scholar
• HorneRWeinmanJPatients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illnessJ Psychosom Res199947655556710661603
   PubMed Web of Science ®Google Scholar
• HorneRHankinsMJenkinsRThe Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and researchQual Health Care200110313514011533420
   PubMedGoogle Scholar
• HellerMKChapmanSCHorneRBeliefs about medication predict the misattribution of a common symptom as a medication side effect – Evidence from an analogue online studyJ Psychosom Res201579651952926519128
   PubMed Web of Science ®Google Scholar
• HershmanDLKushiLHShaoTEarly discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patientsJ Clin Oncol201028274120412820585090
   PubMed Web of Science ®Google Scholar
• CorterALFindlayMBroomRPorterDPetrieKJBeliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancerBr J Health Psychol201318116818123134580
   PubMed Web of Science ®Google Scholar
• GrassiLMeggiolaroEBerardiMABeliefs about medicines, doctor-patient relationship, and coping among European patients with cancerPsychooncology201726228228527072393
   PubMed Web of Science ®Google Scholar
• van der Feltz-CornelisCMvan OppenPvan MarwijkHWde BeursEvan DyckRA patient-doctor relationship questionnaire (PDRQ-9) in primary care: development and psychometric evaluationGen Hosp Psychiatry200426211512015038928
   PubMed Web of Science ®Google Scholar
• ZengerMSchaefertRvan der Feltz-CornelisCBrählerEHäuserWValidation of the Patient-Doctor-Relationship Questionnaire (PDRQ-9) in a representative cross-sectional German population surveyPLoS One201493e9196424637904
   PubMed Web of Science ®Google Scholar
• MahlerCHermannKHorneRAssessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in GermanyJ Eval Clin Pract201016357457920210821
   PubMed Web of Science ®Google Scholar
• PartridgeAHWangPSWinerEPAvornJNonadherence to adjuvant tamoxifen therapy in women with primary breast cancerJ Clin Oncol200321460260612586795
   PubMed Web of Science ®Google Scholar
• NoensLvan LierdeMAde BockRPrevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO studyBlood2009113225401541119349618
   PubMed Web of Science ®Google Scholar
• AtkinsLFallowfieldLIntentional and non-intentional non-adherence to medication amongst breast cancer patientsEur J Cancer200642142271227616644208
   PubMed Web of Science ®Google Scholar
• BarthélémyPAsmane-de La PorteIMeyerNAdherence and patients’ attitudes to oral anticancer drugs: a prospective series of 201 patients focusing on targeted therapiesOncology20158811825247774
   PubMed Web of Science ®Google Scholar
• KirkMCHudisCAInsight into barriers against optimal adherence to oral hormonal therapy in women with breast cancerClin Breast Cancer20088215516118621612
   PubMed Web of Science ®Google Scholar
• EliassonLCliffordSBarberNMarinDExploring chronic myeloid leukemia patients’ reasons for not adhering to the oral anticancer drug imatinib as prescribedLeuk Res201135562663021095002
   PubMed Web of Science ®Google Scholar
• KawakamiKNakamotoEYokokawaTPatients’ self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysisPatient Prefer Adherence2015956156725914526
   PubMed Web of Science ®Google Scholar
• KimuraMNakashimaKUsamiEAdherence and awareness of the therapeutic intent of oral anticancer agents in an outpatient settingOncol Lett2015952341234626137068
   PubMed Web of Science ®Google Scholar
• DinkelASchneiderASchmutzerGBrählerEHenningsenPHäuserWThe quality of the family physician-patient relationship. Patient-related predictors in a sample representative for the German populationPsychother Psychosom Med Psychol2016663–412012727035441
   PubMed Web of Science ®Google Scholar
• LassereYHoffPManagement of hand-foot syndrome in patients treated with capecitabine (Xeloda)Eur J Oncol Nurs20048Suppl 1S31S4015341880
   PubMedGoogle Scholar
• JeffordMTattersallMHInforming and involving cancer patients in their own careLancet Oncol200231062963712372725
   PubMed Web of Science ®Google Scholar
• HaynesRBTaylorDWSackettDLGibsonESBernholzCDMukherjeeJCan simple clinical measurements detect patient noncompliance?Hypertension1980267577647007235
   PubMed Web of Science ®Google Scholar
• FeelyMLindsaySSwinnRWilliamsCBirdHPullarTAn evaluation of therapeutic drug (metabolite) monitoring to study compliance with allopurinol for goutProc BPS1993112P113P
   Google Scholar
• DeschampsAEde GeestSVandammeAMBobbaersHPeetermansWEvan WijngaerdenEDiagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standardsAIDS Patient Care STDS200822973574318754705
   PubMed Web of Science ®Google Scholar
• HuangWCChenCYLinSJChangCSMedication adherence to oral anticancer drugs: systematic reviewExpert Rev Anticancer Ther201616442343226935964
   PubMed Web of Science ®Google Scholar
• PartridgeAHAvornJWangPSWinerEPAdherence to therapy with oral antineoplastic agentsJ Natl Cancer Inst200294965266111983753
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• WuSCheeDUgaldeAButowPSeymourJSchofieldPLack of congruence between patients’ and health professionals’ perspectives of adherence to imatinib therapy in treatment of chronic myeloid leukemia: A qualitative studyPalliat Support Care201513225526324524212
   PubMed Web of Science ®Google Scholar
• HardyHKumarVDorosGRandomized controlled trial of a personalized cellular phone reminder system to enhance adherence to anti-retroviral therapyAIDS Patient Care STDS201125315316121323532
   PubMed Web of Science ®Google Scholar
• WuJYLeungWYChangSEffectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trialBMJ2006333756752216916809
   PubMed Web of Science ®Google Scholar
• KrolopLKoYDSchwindtPFSchumacherCFimmersRJaehdeUAdherence management for patients with cancer taking capecitabine: a prospective two-arm cohort studyBMJ Open201337e003139
   Web of Science ®Google Scholar
• TwiggMJWrightDKirkdaleCLDesboroughJAThornleyTThe UK Pharmacy Care Plan service: Description, recruitment and initial views on a new community pharmacy interventionPLoS One2017124e017450028369064
   PubMed Web of Science ®Google Scholar
• SimonsSRingsdorfSBraunMEnhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical careSupport Care Cancer20111971009101820552377
   PubMed Web of Science ®Google Scholar
• SpoelstraSLSikorskiiAGivenCWAdult Cancer Patient Recruitment and Enrollment into Cell Phone Text Message TrialsTelemed J E Health2016221083684226982446
   PubMed Web of Science ®Google Scholar
• SpoelstraSLSikorskiiAMajumderABurhennPSSchuellerMGivenBOral Anticancer Agents: An Intervention to Promote Medication Adherence and Symptom ManagementClin J Oncol Nurs201721215716028315545
   PubMed Web of Science ®Google Scholar